Clinical trial Recruiting at 2 sites Interventional Ages Any age to 18

New Non-Invasive Blood Pressure (NIBP) Enhancement for Neonates and Children

Official title: Non-Invasive Blood Pressure Accuracy Study for Neonate and Pediatric Subject Populations

Run by GE Healthcare · NCT07684885 · Data updated 2026-11-12

This study tests a new NIBP device enhancement in neonates and kids to see if it can measure blood pressure more accurately.

More Blood Pressure trials

Quick facts

Study typeInterventional
AgesAny age to 18 Years
SexAll
Enrollment110 (estimated)
SponsorGE Healthcare
Industry-sponsored
Locations2 sites (Helsinki and 1 other locations)
StatusRecruiting
StartedMay 14, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 6, 2026
Trial IDNCT07684885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children from birth through 17 years old with an arterial line in place and suitable cuff sizes (3–33 cm limb circumference for the device, or 38–50 cm thigh circumference).

Probably not a fit

Some patients, such as those with peripheral arterial disease or hemodynamic instability, may not benefit from the device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial collects clinical data to validate the accuracy of NIBP measurement algorithms on the NIBP Standard Parameter Module following IEC 80601-2-30:2018 and ISO 81060-2:2018+AMD2:2024. It is an interventional study focusing on automated intermittent NIBP measurements in pediatric populations. Participants are admitted pediatric patients or neonates with an arterial line as part of standard care and who fit specific cuff sizes. Data will be gathered in a hospital setting to compare the enhanced NIBP measurements against invasive blood pressure readings. The study aims to support regulatory-grade validation for safer, easier blood pressure monitoring in children.

Why it matters

Potential benefit: If successful, the enhanced NIBP measurement could improve accuracy and reliability of non-invasive BP readings in neonates and children.

How similar studies have gone: Prior standards-based validation studies exist for NIBP devices; this study adapts established methods for pediatric populations, with goal of robust accuracy data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age requirement: 0 to \< 18 years.
* For children under 15 years old: Has a guardian or other legal representative who is able to provide consent of a guardian OR
* For children between the age of 15-17 years; able to provide written consent form and the legal guardians can be reached to be informed of the study participation.
* Have an upper limb (right OR left side) that fits the cuff size of the device (circumference ranging 3 cm to 33 cm) OR have a thigh (right OR left side) that fits a cuff size of the device (circumference ranging 38 to 50 cm).
* Have an arterial line as a standard of care, which measures invasive blood pressure.
* Expected to remain in the unit for the duration of the study procedure.

Exclusion Criteria:

* Have previously participated in this study (no subject may participate more than once).
* Subjects with peripheral arterial diseases (causing left/right arm difference).
* Hemodynamically unstable subjects Subjects with complications on vasoactive agents at discretion of the Investigator.
* Exhibited injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the Investigator, may prevent proper cuff application or functioning.
* Are suffering from infection(s) or immunocompromised subjects that require isolation.
* For adolescents of child-bearing potential, who are currently pregnant, suspected to be pregnant, or are currently lactating.
* PI, designee or caring physician decision due to subject health conditions

Where it's running

  • Helsinki University Hospital
    Helsinki, Finland
    Recruiting
  • Helsinki University Hospital
    Helsinki, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.